会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Apparatus for automatically determining the optimum amounts of reagents to be added to a liquid for its clarification
    • 用于自动确定要添加到液体中的试剂的最佳数量的装置进行澄清
    • US3731807A
    • 1973-05-08
    • US3731807D
    • 1970-07-07
    • DEGREMONT
    • LOUBOUTIN RDAUDENARDE C
    • C02F1/52G01N21/83G05D21/02B01D21/01
    • G01N21/83C02F1/5209G05D21/02
    • Apparatus for automatically determining the optimum proportion of coagulant reagent to be added to a liquid in order to clarify same by coagulation of the substances in colloidal suspension therein, which comprises a plurality of mixing vessels into which predetermined quantities of liquid and reagent are introduced and in which these liquid and reagent are adapted to mix together, the resulting mixture being subsequently separated into a decanting fraction and a supernatant fraction, means for measuring the turbidity of said supernatant fraction, said means consisting advantageously of one or a plurality of turbidimeters, and other means such as computer for analyzing and comparing the measurements made in said turbidimeter or turbidimeters, and determining the optimum proportion of reagent to be added to the liquid.
    • 用于自动确定要添加到液体中的凝结剂的最佳比例的装置,以便通过其中胶体悬浮液中的物质的凝结来澄清它,其包括多个混合容器,其中引入了预定量的液体和试剂, 将这些液体和试剂混合在一起,将所得混合物随后分离成倾析馏分和上清液部分,用于测量所述上清液部分的浊度的装置,所述装置有利地由一个或多个浊度计和其它 用于分析和比较在所述浊度计或浊度计中进行的测量的计算机,以及确定待添加到液体中的试剂的最佳比例。
    • 9. 发明申请
    • SAMPLE ANALYSIS METHODS
    • 样本分析方法
    • US20170045441A1
    • 2017-02-16
    • US15340615
    • 2016-11-01
    • ARCHIMEJ TECHNOLOGY
    • Mejdi Nciri
    • G01N21/31
    • G01N21/31G01J3/0208G01J3/10G01J3/14G01J3/42G01J3/4406G01J2003/1282G01N21/6458G01N21/83G01N33/49G01N2021/3129G01N2021/3196G01N2021/6417G02B27/1006
    • The invention generally relates to methods for determining a concentration of at least one target analyte in a heterogeneous sample and methods for detecting a condition. In certain aspects, the inventions provides methods that involve illuminating a heterogeneous sample, such as a biological sample, including at least one target analyte with polychromatic light, receiving luminous data of the heterogeneous sample and the at least one target analyte with a detector without splitting the polychromatic light into individual wavelengths and generating spectral data therefrom. The spectral data is then converted into a concentration of the at least one target analyte in the biological sample by comparing the spectral data to a database comprising known spectra already associated with concentration levels.
    • 本发明一般涉及用于确定异质样品中至少一种目标分析物的浓度的方法和用于检测病症的方法。 在某些方面,本发明提供了涉及照射诸如生物样品的异质样品(包括至少一种具有多色光的目标分析物)的方法,使用检测器接收异质样品和至少一种目标分析物的发光数据而不分裂 将多色光转换为单个波长并从其产生光谱数据。 然后通过将光谱数据与包括已经与浓度水平相关联的已知光谱的数据库进行比较,将光谱数据转换成生物样品中至少一种目标分析物的浓度。
    • 10. 发明申请
    • METHOD OF AGGLUTINATION IMMUNOASSAY
    • 免疫免疫法的方法
    • US20160195522A1
    • 2016-07-07
    • US14894207
    • 2014-06-02
    • SEKISUI MEDICAL CO., LTD.
    • Hiroshi TAKAHASHITadaaki YOSHIDAYoshimasa BANBAYuki TAKAHASHI
    • G01N33/543
    • G01N33/54313G01N21/31G01N21/47G01N21/59G01N21/83G01N2021/1734G01N2333/705
    • The present invention provides a particle enhanced agglutination immunoassay including the steps of: mixing a sample solution containing an analyte with a solution containing insoluble carrier particles carrying a binding partner or binding partners for the analyte to prepare a mixed solution; determining a variation (i) in intensity of light scattered from the mixed solution based on a difference in intensity of scattered light between first and second time points; determining a variation (ii) in absorbance of the mixed solution based on a difference in absorbance between third and fourth time points; and correlating the determined variation (i) in intensity of scattered light and the determined variation (ii) in absorbance with an amount of the analyte present in the sample using a calibration curve plotted based on the variation in intensity of scattered light and a calibration curve plotted based on the variation in absorbance. The present invention employs measurements of the intensity of scattered light and the absorbance in combination for a single assay, and thus provides a particle enhanced agglutination immunoassay which achieves higher sensitivity and a wider dynamic range than conventional assays.
    • 本发明提供一种增强粒细胞的凝集免疫测定法,其包括以下步骤:将含有分析物的样品溶液与含有不溶性载体颗粒的溶液混合,所述溶液携带用于分析物的结合配偶体或结合配偶体以制备混合溶液; 基于第一和第二时间点之间的散射光的强度差,确定从混合溶液散射的光的强度的变化(i); 基于第三和第四时间点之间的吸光度差,确定混合溶液的吸光度的变化(ii); 并使用基于散射光的强度和校正曲线的变化绘制的校准曲线将确定的散射光强度和所确定的吸光度变化(ii)与样品中存在的分析物的量相关联 基于吸光度的变化绘制。 本发明采用单一测定结合测量散射光的强度和吸光度,从而提供与常规测定相比更高的灵敏度和更广的动态范围的增强粒子的凝集免疫测定。